| Old Articles: <Older 31221-31230 Newer> |
 |
The Motley Fool July 23, 2008 Ryan Fuhrmann |
Regional Banks to Bank On These three regional banks seem to be successfully navigating the current industry turmoil.  |
The Motley Fool July 23, 2008 Nick Kapur |
Don't Buy the Hype Before you buy, scrutinize new, hyped-up issues through the lens of a value hunter. What are you buying? And how much is it going to cost you?  |
The Motley Fool July 23, 2008 Alex Dumortier |
OptionsXpress Holds Its Own optionsXpress's earnings report demonstrates the attractiveness of its capital-light franchise and the growth in its market.  |
The Motley Fool July 23, 2008 Toby Shute |
A Bonanza for Big Ag Tractor titan CNH Global is tearing it up, with agricultural equipment driven by strength around the globe, and construction equipment supported by Latin America and other emerging markets.  |
The Motley Fool July 23, 2008 Dave Mock |
Broadcom's Show of Strength Unfazed by slowdowns in some chip sectors, Broadcom has again delivered another impressive quarter of earnings.  |
The Motley Fool July 23, 2008 Anders Bylund |
Reading Between SanDisk's Headlines The company is planning to make some changes to its business model in order to improve its financial health.  |
The Motley Fool July 23, 2008 Christopher Barker |
Full Steam Ahead for Norfolk Southern Norfolk Southern beats expectations with record earnings.  |
The Motley Fool July 23, 2008 Brian Lawler |
No Picking at Biogen At a time in which all of its top drugs experienced at least double-digit percentage sales growth, there aren't many issues to poke at with Biogen Idec's just-released second-quarter financial results.  |
The Motley Fool July 23, 2008 David Lee Smith |
Oilfield Services Results? Check! Energy's going strong in the U.S. and worldwide. With the international and domestic energy scenes both looking positive for the first time in ages, it's time to keep especially close tabs on the oilfield services group.  |
The Motley Fool July 23, 2008 Brian Orelli |
Leaner Boston Scientific Isn't Looking Healthy Investors are rightfully growing weary of Boston Scientific's ability to cut expenses on flat sales, and they send the stock down.  |
| <Older 31221-31230 Newer> Return to current articles. |